Lipids and Age-related Macular Degeneration

Abstract Given the considerable public health burden imposed by age-related macular degeneration (AMD), much effort has been directed towards elucidating principles of pathogenesis in order to identify risk factors and develop preventive measures and treatments. Together with epidemiological evidenc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Survey of ophthalmology 2011-05, Vol.56 (3), p.195-213
Hauptverfasser: Kishan, Amar U., BA, Modjtahedi, Bobeck S., MD, Martins, Elisabeth N., MD, Modjtahedi, Sara P., MD, Morse, Lawrence S., MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 213
container_issue 3
container_start_page 195
container_title Survey of ophthalmology
container_volume 56
creator Kishan, Amar U., BA
Modjtahedi, Bobeck S., MD
Martins, Elisabeth N., MD
Modjtahedi, Sara P., MD
Morse, Lawrence S., MD, PhD
description Abstract Given the considerable public health burden imposed by age-related macular degeneration (AMD), much effort has been directed towards elucidating principles of pathogenesis in order to identify risk factors and develop preventive measures and treatments. Together with epidemiological evidence linking cardiovascular risk factors with AMD risk and basic science work examining the role of lipid metabolism in AMD, numerous human studies have assayed a potential relationship between dietary lipids and the development of AMD. We examine the evidence for a role for lipid metabolism in AMD, highlighting key basic biochemical principles, work in animal models, and relevant human studies. The topics of lipoprotein modulation and omega-3 fatty acid intake receive special attention from both a basic science and clinical study standpoint. The evidence suggests that consumption of omega-3 fatty acids, perhaps in concert with antioxidants, may constitute a rational preventative strategy against AMD development, though, absent an appropriately developed double-blind, randomized control trial, insufficient data exist to recommend implementation in the clinical setting at this time.
doi_str_mv 10.1016/j.survophthal.2010.08.008
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_867735918</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039625710001591</els_id><sourcerecordid>867735918</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-6ccfbcaf161db6540eb045f6f62d6c2a3af88ab9bf078efc10313baa228d5bd43</originalsourceid><addsrcrecordid>eNqNkU1LxDAQhoMoun78BVlPHqTrJGnT9CLI-gkrHtRzSJOJZu22a9IK_nuzrIp48jTD8MwMPC8hRxQmFKg4nU_iEN675Uv_opsJgzQHOQGQG2REZVllnEO-SUYAvMoEK8odshvjHAByXpXbZIfR1AjIR-Rk5pfexrFu7fj8GbOAje7Rju-0GRodxhf4jC0G3fuu3SdbTjcRD77qHnm6unyc3mSz--vb6fksM7ngfSaMcbXRjgpqa1HkgDXkhRNOMCsM01w7KXVd1Q5Kic5Q4JTXWjMmbVHbnO-R4_XdZejeBoy9WvhosGl0i90QlRRlyYuKyn-QrKygYiKR1Zo0oYsxoFPL4Bc6fCgKaiVVzdUvqWolVYFUSWraPfz6MtQLtD-b3xYTMF0DmKy8ewwqGo-tQesDml7Zzv_rzdmfK6bxrTe6ecUPjPNuCG3SrqiKTIF6WKW7CpemXGnSwT8Bz7Wi-A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>862790926</pqid></control><display><type>article</type><title>Lipids and Age-related Macular Degeneration</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Kishan, Amar U., BA ; Modjtahedi, Bobeck S., MD ; Martins, Elisabeth N., MD ; Modjtahedi, Sara P., MD ; Morse, Lawrence S., MD, PhD</creator><creatorcontrib>Kishan, Amar U., BA ; Modjtahedi, Bobeck S., MD ; Martins, Elisabeth N., MD ; Modjtahedi, Sara P., MD ; Morse, Lawrence S., MD, PhD</creatorcontrib><description>Abstract Given the considerable public health burden imposed by age-related macular degeneration (AMD), much effort has been directed towards elucidating principles of pathogenesis in order to identify risk factors and develop preventive measures and treatments. Together with epidemiological evidence linking cardiovascular risk factors with AMD risk and basic science work examining the role of lipid metabolism in AMD, numerous human studies have assayed a potential relationship between dietary lipids and the development of AMD. We examine the evidence for a role for lipid metabolism in AMD, highlighting key basic biochemical principles, work in animal models, and relevant human studies. The topics of lipoprotein modulation and omega-3 fatty acid intake receive special attention from both a basic science and clinical study standpoint. The evidence suggests that consumption of omega-3 fatty acids, perhaps in concert with antioxidants, may constitute a rational preventative strategy against AMD development, though, absent an appropriately developed double-blind, randomized control trial, insufficient data exist to recommend implementation in the clinical setting at this time.</description><identifier>ISSN: 0039-6257</identifier><identifier>EISSN: 1879-3304</identifier><identifier>DOI: 10.1016/j.survophthal.2010.08.008</identifier><identifier>PMID: 21439604</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Age-related macular degeneration ; Animals ; cholesterol ; diet ; Dietary Fats - administration &amp; dosage ; docosahexaenoic acid ; eicosapentaenoic acid ; human ; Humans ; Lipid Metabolism - physiology ; lipids ; Macular Degeneration - metabolism ; Macular Degeneration - prevention &amp; control ; metabolism ; omega-3 ; Ophthalmology ; Risk Factors ; statin</subject><ispartof>Survey of ophthalmology, 2011-05, Vol.56 (3), p.195-213</ispartof><rights>Elsevier Inc.</rights><rights>2011 Elsevier Inc.</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-6ccfbcaf161db6540eb045f6f62d6c2a3af88ab9bf078efc10313baa228d5bd43</citedby><cites>FETCH-LOGICAL-c463t-6ccfbcaf161db6540eb045f6f62d6c2a3af88ab9bf078efc10313baa228d5bd43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0039625710001591$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21439604$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kishan, Amar U., BA</creatorcontrib><creatorcontrib>Modjtahedi, Bobeck S., MD</creatorcontrib><creatorcontrib>Martins, Elisabeth N., MD</creatorcontrib><creatorcontrib>Modjtahedi, Sara P., MD</creatorcontrib><creatorcontrib>Morse, Lawrence S., MD, PhD</creatorcontrib><title>Lipids and Age-related Macular Degeneration</title><title>Survey of ophthalmology</title><addtitle>Surv Ophthalmol</addtitle><description>Abstract Given the considerable public health burden imposed by age-related macular degeneration (AMD), much effort has been directed towards elucidating principles of pathogenesis in order to identify risk factors and develop preventive measures and treatments. Together with epidemiological evidence linking cardiovascular risk factors with AMD risk and basic science work examining the role of lipid metabolism in AMD, numerous human studies have assayed a potential relationship between dietary lipids and the development of AMD. We examine the evidence for a role for lipid metabolism in AMD, highlighting key basic biochemical principles, work in animal models, and relevant human studies. The topics of lipoprotein modulation and omega-3 fatty acid intake receive special attention from both a basic science and clinical study standpoint. The evidence suggests that consumption of omega-3 fatty acids, perhaps in concert with antioxidants, may constitute a rational preventative strategy against AMD development, though, absent an appropriately developed double-blind, randomized control trial, insufficient data exist to recommend implementation in the clinical setting at this time.</description><subject>Age-related macular degeneration</subject><subject>Animals</subject><subject>cholesterol</subject><subject>diet</subject><subject>Dietary Fats - administration &amp; dosage</subject><subject>docosahexaenoic acid</subject><subject>eicosapentaenoic acid</subject><subject>human</subject><subject>Humans</subject><subject>Lipid Metabolism - physiology</subject><subject>lipids</subject><subject>Macular Degeneration - metabolism</subject><subject>Macular Degeneration - prevention &amp; control</subject><subject>metabolism</subject><subject>omega-3</subject><subject>Ophthalmology</subject><subject>Risk Factors</subject><subject>statin</subject><issn>0039-6257</issn><issn>1879-3304</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1LxDAQhoMoun78BVlPHqTrJGnT9CLI-gkrHtRzSJOJZu22a9IK_nuzrIp48jTD8MwMPC8hRxQmFKg4nU_iEN675Uv_opsJgzQHOQGQG2REZVllnEO-SUYAvMoEK8odshvjHAByXpXbZIfR1AjIR-Rk5pfexrFu7fj8GbOAje7Rju-0GRodxhf4jC0G3fuu3SdbTjcRD77qHnm6unyc3mSz--vb6fksM7ngfSaMcbXRjgpqa1HkgDXkhRNOMCsM01w7KXVd1Q5Kic5Q4JTXWjMmbVHbnO-R4_XdZejeBoy9WvhosGl0i90QlRRlyYuKyn-QrKygYiKR1Zo0oYsxoFPL4Bc6fCgKaiVVzdUvqWolVYFUSWraPfz6MtQLtD-b3xYTMF0DmKy8ewwqGo-tQesDml7Zzv_rzdmfK6bxrTe6ecUPjPNuCG3SrqiKTIF6WKW7CpemXGnSwT8Bz7Wi-A</recordid><startdate>20110501</startdate><enddate>20110501</enddate><creator>Kishan, Amar U., BA</creator><creator>Modjtahedi, Bobeck S., MD</creator><creator>Martins, Elisabeth N., MD</creator><creator>Modjtahedi, Sara P., MD</creator><creator>Morse, Lawrence S., MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U1</scope><scope>7U2</scope><scope>C1K</scope></search><sort><creationdate>20110501</creationdate><title>Lipids and Age-related Macular Degeneration</title><author>Kishan, Amar U., BA ; Modjtahedi, Bobeck S., MD ; Martins, Elisabeth N., MD ; Modjtahedi, Sara P., MD ; Morse, Lawrence S., MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-6ccfbcaf161db6540eb045f6f62d6c2a3af88ab9bf078efc10313baa228d5bd43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Age-related macular degeneration</topic><topic>Animals</topic><topic>cholesterol</topic><topic>diet</topic><topic>Dietary Fats - administration &amp; dosage</topic><topic>docosahexaenoic acid</topic><topic>eicosapentaenoic acid</topic><topic>human</topic><topic>Humans</topic><topic>Lipid Metabolism - physiology</topic><topic>lipids</topic><topic>Macular Degeneration - metabolism</topic><topic>Macular Degeneration - prevention &amp; control</topic><topic>metabolism</topic><topic>omega-3</topic><topic>Ophthalmology</topic><topic>Risk Factors</topic><topic>statin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kishan, Amar U., BA</creatorcontrib><creatorcontrib>Modjtahedi, Bobeck S., MD</creatorcontrib><creatorcontrib>Martins, Elisabeth N., MD</creatorcontrib><creatorcontrib>Modjtahedi, Sara P., MD</creatorcontrib><creatorcontrib>Morse, Lawrence S., MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Survey of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kishan, Amar U., BA</au><au>Modjtahedi, Bobeck S., MD</au><au>Martins, Elisabeth N., MD</au><au>Modjtahedi, Sara P., MD</au><au>Morse, Lawrence S., MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lipids and Age-related Macular Degeneration</atitle><jtitle>Survey of ophthalmology</jtitle><addtitle>Surv Ophthalmol</addtitle><date>2011-05-01</date><risdate>2011</risdate><volume>56</volume><issue>3</issue><spage>195</spage><epage>213</epage><pages>195-213</pages><issn>0039-6257</issn><eissn>1879-3304</eissn><abstract>Abstract Given the considerable public health burden imposed by age-related macular degeneration (AMD), much effort has been directed towards elucidating principles of pathogenesis in order to identify risk factors and develop preventive measures and treatments. Together with epidemiological evidence linking cardiovascular risk factors with AMD risk and basic science work examining the role of lipid metabolism in AMD, numerous human studies have assayed a potential relationship between dietary lipids and the development of AMD. We examine the evidence for a role for lipid metabolism in AMD, highlighting key basic biochemical principles, work in animal models, and relevant human studies. The topics of lipoprotein modulation and omega-3 fatty acid intake receive special attention from both a basic science and clinical study standpoint. The evidence suggests that consumption of omega-3 fatty acids, perhaps in concert with antioxidants, may constitute a rational preventative strategy against AMD development, though, absent an appropriately developed double-blind, randomized control trial, insufficient data exist to recommend implementation in the clinical setting at this time.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>21439604</pmid><doi>10.1016/j.survophthal.2010.08.008</doi><tpages>19</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0039-6257
ispartof Survey of ophthalmology, 2011-05, Vol.56 (3), p.195-213
issn 0039-6257
1879-3304
language eng
recordid cdi_proquest_miscellaneous_867735918
source MEDLINE; Elsevier ScienceDirect Journals
subjects Age-related macular degeneration
Animals
cholesterol
diet
Dietary Fats - administration & dosage
docosahexaenoic acid
eicosapentaenoic acid
human
Humans
Lipid Metabolism - physiology
lipids
Macular Degeneration - metabolism
Macular Degeneration - prevention & control
metabolism
omega-3
Ophthalmology
Risk Factors
statin
title Lipids and Age-related Macular Degeneration
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T22%3A11%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lipids%20and%20Age-related%20Macular%20Degeneration&rft.jtitle=Survey%20of%20ophthalmology&rft.au=Kishan,%20Amar%20U.,%20BA&rft.date=2011-05-01&rft.volume=56&rft.issue=3&rft.spage=195&rft.epage=213&rft.pages=195-213&rft.issn=0039-6257&rft.eissn=1879-3304&rft_id=info:doi/10.1016/j.survophthal.2010.08.008&rft_dat=%3Cproquest_cross%3E867735918%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=862790926&rft_id=info:pmid/21439604&rft_els_id=S0039625710001591&rfr_iscdi=true